交易中 11-05 10:54:25 美东时间
0.000
0.00%
NusaTrip Inc., a travel platform specializing in Southeast Asia and Asia-Pacific, faced a trading suspension on its securities by the SEC starting Oct. 9, 2025, due to suspected price manipulation via social media recommendations. The Company has denied involvement and is cooperating with regulators, with trading currently halted since Oct. 23. Investors are advised to rely on official communications.
10-28 13:50
Nutriband Inc. announced that founder Gareth Sheridan has returned as CEO, succeeding Co-Founder Serguei Melnik who led the company from August 10 to October 27. Sheridan will guide Nutriband toward the 2026 NDA filing for AVERSA Fentanyl, an innovative abuse-deterrent opioid patch designed to reduce misuse and accidental exposure. Targeting annual U.S. sales of $80–200 million, AVERSA Fentanyl addresses a global need for safer pain management. T...
10-27 11:00
<p>The Nasdaq Stock Market announced that trading in NusaTrip Incorporated (NUTR) has been halted due to the company's failure to provide additional requested information. The Securities and Exchange Commission previously suspended trading from October 9 to October 22, 2025. The last sale price of NusaTrip's shares was $9.00. Trading will remain paused until the company fulfills Nasdaq's information requirements. Additional details are available ...
10-23 10:00
An announcement from NusaTrip Incorporated ( ($NUTR) ) is now available. On Oct...
10-15 04:40
Society Pass Inc. (NASDAQ: SOPA) shares soared after Ascendiant Capital Markets LLC issued a positive equity report.
10-06 23:56
Nutriband Inc. will participate in the MicroCap Rodeo Conference on Thursday, September 25, 2025, in New York City. Company Chairman Serghuei Melnik will discuss the company's operational highlights, growth initiatives, and strategic direction for its AVERSA abuse-deterrent technology. The presentation will be live at 10AM and available for virtual viewing. The conference will feature group presentations, one-on-one meetings with investors, indus...
09-24 20:05
Nutriband Inc. reported strong financial results for the first half of 2025, with a cash position of $6.9 million and total assets of $10.17 million. The company's revenue grew 50.87% year-over-year to $1.29 million, driven by its kinesiology tape contract manufacturing services. Development of its lead product, AVERSA™ Fentanyl, is progressing, with an upcoming Type C meeting set for September 18. The product, if approved, could become the first...
09-10 13:15
NusaTrip Incorporated ( ($NUTR) ) has shared an announcement. NusaTrip Incorpor...
09-05 23:28
<p>NusaTrip Inc. (Nasdaq: NUTR), a leading travel ecosystem in Southeast Asia and Asia-Pacific, has filed its 2Q 2025 Form 10-Q with the SEC. The company reported a 472% year-on-year revenue growth to $993,041 and a 251% quarter-on-quarter increase. It also achieved an operating profit of $408,701, turning profitable for the first time. With $6.9 million in cash, NusaTrip is well-positioned to complete its new travel platform in 4Q 2025 and pursu...
09-03 12:00
2025年8月27日 – 上海,由礼来中国发起的“身体抵抗解码展”在上海静安区吴江路盛大开幕,本次展览将持续4天,旨在提升公众对肥胖疾病的认知,树立科学的疾病防...
08-28 14:59